Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03048981Completed
Open-label, single-arm trial, sponsored by Region Skåne. Primary endpoints: Thrombocyte aggregation measured with multiple electrode aggregometry at 7 days and Thrombocyte aggregation measured with Cellix's microfluidic pumps and biochips at 7 days. Started Mar 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03048981.